Chet Kwon

Identification of Novel Inhibitors of the Transforming Growth Factor β1 (TGF-β1) Type 1 Receptor (ALK5)

James F. Callahan, Joelle L. Burgess, James A. Fornwald et al. · Journal of Medicinal Chemistry · 2002 · 309 citations · Full text

Drug Target, Pharmacotherapy, Cell Growth +18

Discovery of Orally Active Nonpeptide Vitronectin Receptor Antagonists Based on a 2-Benzazepine Gly-Asp Mimetic

William H. Miller, Doreen Alberts, Pradip K. Bhatnagar et al. · Journal of Medicinal Chemistry · 1999 · 116 citations · Full text

Pharmacotherapy, Experimental Pharmacology, Pharmacodynamic Modeling +16

Discovery of Potent Nonpeptide Vitronectin Receptor (α_Vβ₃) Antagonists

Richard M. Keenan, William H. Miller, Chet Kwon et al. · Journal of Medicinal Chemistry · 1997 · 114 citations · Full text

Molecular Pharmacology, Medicinal Chemistry, Biochemistry +14

Potent, Selective, Orally Active 3-Oxo-1,4-benzodiazepine GPIIb/IIIa Integrin Antagonists

James M. Samanen, Fadia E. Ali, Linda S. Barton et al. · Journal of Medicinal Chemistry · 1996 · 72 citations · Full text

Altmetric Attention Score, Pharmacotherapy, Experimental Pharmacology +17

Combinatorial chemistry. Use of an intramolecular ruthenium catalyzed olefin/alkyne metathesis reaction in tandem with a Diels-Alder cycloaddition reaction to construct functionalized hexahydroisoindoles

Dirk A. Heerding, Dennis T. Takata, Chet Kwon et al. · Tetrahedron Letters · 1998 · 51 citations

Combinatorial Chemistry, Engineering, Alkene Metathesis +7